Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Spec. Buy
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Canaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Buy to Spec. Buy with a price target of $10.00.
Shares of Concordia Healthcare closed at $6.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts Marathon Oil (MRO) at Hold
- Argus Downgrades Cognizant Technology Solutions (CTSH) to Hold
- UBS Cuts AT&T (T) to Neutral on Lower EPS Estimates
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesCanaccord Genuity
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!